Sensei Biotherapeutics extends stockholder rights plan to March 2025, removes 'acting in concert' definition

Sensei Biotherapeutics, Inc.

Second Amendment to Rights Agreement extends expiration date to March 7, 2025 (from March 7, 2024).
The amendment eliminates the 'acting in concert' beneficial ownership provision from the Rights Agreement.
Rights remain subject to earlier redemption, exchange, or termination per the agreement.
Amendment is between Sensei Biotherapeutics and Equiniti Trust Company, LLC, as Rights Agent.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.